Inventor
CHEN HONGMING
CN50 patents
⚠️ This page may combine multiple inventors who share the name “CHEN HONGMING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV JOHNS HOPKINS
19 patentsUS9827191B2Nov 28, 2017
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS13 citations92
US10993908B2May 4, 2021
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS5 citations84
US10945948B2Mar 16, 2021
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS4 citations84
US10940108B2Mar 9, 2021
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS6 citations84
US10857096B2Dec 8, 2020
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS5 citations84
US10688045B2Jun 23, 2020
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS7 citations84
US10646437B2May 12, 2020
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS7 citations84
US10646436B2May 12, 2020
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS7 citations84
US11642317B2May 9, 2023
Nanocrystals, compositions, and methods that aid particle transport in mucus
UNIV JOHNS HOPKINS1 citations73
US11596599B2Mar 7, 2023
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS2 citations73
US11219597B2Jan 11, 2022
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS3 citations73
US11219596B2Jan 11, 2022
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS1 citations73
US10864219B2Dec 15, 2020
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS5 citations73
US10736854B2Aug 11, 2020
Nanocrystals, compositions, and methods that aid particle transport in mucus
UNIV JOHNS HOPKINS2 citations73
US10058511B2Aug 28, 2018
Nanocrystals, compositions, and methods that aid particle transport in mucus
UNIV JOHNS HOPKINS2 citations73
US12178920B2Dec 31, 2024
Nanocrystals, compositions, and methods that aid particle transport in mucus
UNIV JOHNS HOPKINS0 citations62
US12115246B2Oct 15, 2024
Compositions and methods for ophthalmic and/or other applications
UNIV JOHNS HOPKINS0 citations62
US11872318B2Jan 16, 2024
Nanocrystals, compositions, and methods that aid particle transport in mucus
UNIV JOHNS HOPKINS0 citations62
US9737491B2Aug 22, 2017
Nanocrystals, compositions, and methods that aid particle transport in mucus
UNIV JOHNS HOPKINS1 citations62
KALA PHARMACEUTICALS INC
7 patentsUS9056057B2Jun 16, 2015
Nanocrystals, compositions, and methods that aid particle transport in mucus
KALA PHARMACEUTICALS INC56 citations97
US10392388B2Aug 27, 2019
Meropenem derivatives and uses thereof
KALA PHARMACEUTICALS INC2 citations71
US9532955B2Jan 3, 2017
Nanocrystals, compositions, and methods that aid particle transport in mucus
KALA PHARMACEUTICALS INC1 citations62
US9393213B2Jul 19, 2016
Nanocrystals, compositions, and methods that aid particle transport in mucus
KALA PHARMACEUTICALS INC2 citations62
US11091487B2Aug 17, 2021
Meropenem derivatives and uses thereof
KALA PHARMACEUTICALS INC0 citations61
US9725451B2Aug 8, 2017
Meropenem derivatives and uses thereof
KALA PHARMACEUTICALS INC0 citations51
US9393212B2Jul 19, 2016
Nanocrystals, compositions, and methods that aid particle transport in mucus
KALA PHARMACEUTICALS INC0 citations51
TRANSFORM PHARMACEUTICALS INC
6 patentsUS6919370B2Jul 19, 2005
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
TRANSFORM PHARMACEUTICALS INC35 citations92
US6758099B2Jul 6, 2004
System and method for optimizing tissue barrier transfer of compounds
TRANSFORM PHARMACEUTICALS INC23 citations92
US7550155B2Jun 23, 2009
Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
TRANSFORM PHARMACEUTICALS INC14 citations84
US7172859B2Feb 6, 2007
System and method for optimizing tissue barrier transfer of compounds
TRANSFORM PHARMACEUTICALS INC2 citations63
US6852526B2Feb 8, 2005
Transdermal assay with magnetic clamp
TRANSFORM PHARMACEUTICALS INC6 citations62
US7915317B2Mar 29, 2011
Aqueous 2,6-diisopropylphenol pharmaceutical compositions
TRANSFORM PHARMACEUTICALS INC1 citations52
MASSACHUSETTS INST TECHNOLOGY
3 patentsUS6060082AMay 9, 2000
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
MASSACHUSETTS INST TECHNOLOGY541 citations99
US6004534ADec 21, 1999
Targeted polymerized liposomes for improved drug delivery
MASSACHUSETTS INST TECHNOLOGY513 citations99
US6387397B1May 14, 2002
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
MASSACHUSETTS INST TECHNOLOGY93 citations98
XIAMEN TIANMA MICRO ELECTRONICS CO LTD
2 patentsUNIV BRITISH COLUMBIA
2 patentsUS9637465B2May 2, 2017
3′ Equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
UNIV BRITISH COLUMBIA2 citations66
US9949945B2Apr 24, 2018
3′ equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
UNIV BRITISH COLUMBIA0 citations45